Obiltoxaximab

Category: Antibiotics



Obiltoxaximab Overview

Obiltoxaximab is a monoclonal antibody designed for the treatment of exposure to Bacillus anthracis spores (etiologic agent of anthrax).[1] This drug was developed by Elusys Therapeutics, Inc. References ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Obiltoxaximab, American Medical Association. This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. v t e v t e Monoclonal antibodies for infectious disease and toxins...

Read more Obiltoxaximab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Obiltoxaximab

Recent Obiltoxaximab Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Obiltoxaximab
  • Injection: 600mg/6ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Obiltoxaximab or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. Site content is Copyright © 2005-2017 MedsChat.com and is protected under U.S. and International Copyright laws. All Rights Reserved. This page was last updated on 25 May 2017.

We are committed to your privacy.

Copyright © 2005-2017 All Rights Reserved. MedsChat® and The People's Medicine Community® are registered trademarks of Limelight Innovations L.L.C.